Monkeypox

Pharmaceutical company SIGA Technologies has announced that its oral therapy tecovirimat has been approved in the UK for the treatment of smallpox, monkeypox, cowpox.  The therapy has also been approved for the treatment of complications following vaccination against smallpox in adults and children with a body weight of at least 13kg.  Tecovirimat works by interfering […]

News round-up by DDW’s Reece Armstrong for 27 – 30 June. Assays for monkeypox, Covid-19 boosters and approvals for oncology drugs are some of the themes of this week’s news round-up. GSK & Sanofi first to report positive data for Omicron booster   GSK and Sanofi have reported positive efficacy data from a co-developed vaccine targeting […]

Clinical diagnostics company Novacyt has launched a polymerase chain reaction (PCR) monkeypox assay in response to the recent outbreak of the virus non-endemic countries.   The company’s monkeypox assay is for research-use only (RUO) and has been developed in two forms for the detection of the virus genome in both of its West African and Central African […]